Literature DB >> 21328089

The IDEAL recommendations and urological innovation.

Peter McCulloch1.   

Abstract

PURPOSE: Like other branches of surgery, Urology has encountered major challenges in aligning the research processes by which new interventions are assessed with the principles of Evidence-Based Medicine. This article explains the IDEAL framework and recommendations and illustrates how they might affect the evaluation of current controversial urological procedures.
METHODS: From an inside perspective, we provide an overview of the efforts of the IDEAL Working Group to date with special emphasis on the field of Urology.
RESULTS: There are clear differences between drugs and interventions in the natural history of innovations. Since the conventional framework for conducting trials of new treatments is largely based on the former, the evaluation of surgical innovations using the same template can encounter significant problems. Difficulties in performing randomized controlled trials of surgical techniques and the persistence of the case series as an important feature of the scientific literature have been the two most controversial aspects of this mismatch between the subject of research and the methodology used. The IDEAL framework provides a description of the process of innovation and development for surgical trials, and the associated recommendations provide a suggested alternative approach to developing study designs, which are appropriate for the specific problems of new techniques.
CONCLUSIONS: IDEAL provides a new framework for surgical innovation that was developed with broad stakeholder input from the surgical community and is expected to have a transformative impact on the way that urologists perform clinical research.

Mesh:

Year:  2011        PMID: 21328089     DOI: 10.1007/s00345-011-0647-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  16 in total

Review 1.  The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review.

Authors:  Isabelle Jacquier; Isabelle Boutron; David Moher; Carine Roy; Philippe Ravaud
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

2.  Standards of reporting of randomized controlled trials in general surgery: can we do better?

Authors:  Sabapathy P Balasubramanian; Martin Wiener; Zeiad Alshameeri; Ravindranath Tiruvoipati; Diana Elbourne; Malcolm W Reed
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

3.  Developing appropriate methodology for the study of surgical techniques.

Authors:  Peter McCulloch
Journal:  J R Soc Med       Date:  2009-02       Impact factor: 5.344

4.  Evaluation and stages of surgical innovations.

Authors:  Jeffrey S Barkun; Jeffrey K Aronson; Liane S Feldman; Guy J Maddern; Steven M Strasberg; Douglas G Altman; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; David R Flum; Paul Glasziou; John C Marshall; Peter McCulloch; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

5.  Surgical research or comic opera: questions, but few answers.

Authors:  R Horton
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Laparoendoscopic single-site (LESS) retroperitoneal adrenalectomy using a homemade single-access platform and standard laparoscopic instruments.

Authors:  Shiu-Dong Chung; Chao-Yuan Huang; Shuo-Meng Wang; Huai-Ching Tai; Yao-Chou Tsai; Shih-Chieh Chueh
Journal:  Surg Endosc       Date:  2010-09-17       Impact factor: 4.584

7.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

8.  Robot-assisted radical prostatectomy: current evaluation of surgical margins in clinically low-, intermediate-, and high-risk prostate cancer.

Authors:  David S Yee; Navneet Narula; Mahul B Amin; Douglas W Skarecky; Thomas E Ahlering
Journal:  J Endourol       Date:  2009-09       Impact factor: 2.942

Review 9.  Robotic-assisted laparoscopic prostatectomy.

Authors:  N L Sharma; N C Shah; D E Neal
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

10.  The challenges faced in the design, conduct and analysis of surgical randomised controlled trials.

Authors:  Jonathan A Cook
Journal:  Trials       Date:  2009-02-06       Impact factor: 2.279

View more
  8 in total

1.  Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography.

Authors:  Berrend G Muller; Daniel M de Bruin; Willemien van den Bos; Martin J Brandt; Juliette F Velu; Mieke T J Bus; Dirk J Faber; Dilara Savci; Patricia J Zondervan; Theo M de Reijke; Pilar Laguna Pes; Jean de la Rosette; Ton G van Leeuwen
Journal:  J Med Imaging (Bellingham)       Date:  2015-07-09

Review 2.  Introducing new technology safely into urological practice.

Authors:  Siska Van Bruwaene; Benjamin Namdarian; Ben Challacombe; Ben Eddy; Ignace Billiet
Journal:  World J Urol       Date:  2018-01-11       Impact factor: 4.226

3.  Ex-vivo study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasound.

Authors:  Mieke T J Bus; Paul Cernohorsky; Daniel M de Bruin; Sybren L Meijer; Geert J Streekstra; Dirk J Faber; Guido M Kamphuis; Patricia J Zondervan; Marcel van Herk; Maria P Laguna Pes; Maik J Grundeken; Martin J Brandt; Theo M de Reijke; Jean J M C H de la Rosette; Ton G van Leeuwen
Journal:  J Med Imaging (Bellingham)       Date:  2018-02-12

Review 4.  Medical and surgical interventions for the treatment of urinary stones in children.

Authors:  Lenka Barreto; Jae Hung Jung; Ameera Abdelrahim; Munir Ahmed; Guy P C Dawkins; Marcin Kazmierski
Journal:  Cochrane Database Syst Rev       Date:  2018-06-02

5.  Coating of mesh grafts for prolapse and urinary incontinence repair with autologous plasma: exploration stage of a surgical innovation.

Authors:  Dimitri Barski; Holger Gerullis; Evangelos Georgas; Andreas Bär; Bernhard Lammers; Albert Ramon; Dirk Ysebaert; Bernd Klosterhalfen; Mihaly Boros; Thomas Otto
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

6.  Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia.

Authors:  Holger Gerullis; Thorsten H Ecke; Dimitri Barski; Carsten Bantel; Andreas Weyland; Jens Uphoff; Thomas Jansen; Friedhelm Wawroschek; Alexander Winter
Journal:  J Int Med Res       Date:  2017-02-13       Impact factor: 1.671

7.  Confocal Laser Endomicroscopy and Optical Coherence Tomography for the Diagnosis of Prostate Cancer: A Needle-Based, In Vivo Feasibility Study Protocol (IDEAL Phase 2A).

Authors:  Abel Swaan; Christophe K Mannaerts; Matthijs Jv Scheltema; Jakko A Nieuwenhuijzen; C Dilara Savci-Heijink; Jean Jmch de la Rosette; R Jeroen A van Moorselaar; Ton G van Leeuwen; Theo M de Reijke; Daniel Martijn de Bruin
Journal:  JMIR Res Protoc       Date:  2018-05-21

Review 8.  The role of focal therapy in the management of localised prostate cancer: a systematic review.

Authors:  Massimo Valerio; Hashim U Ahmed; Mark Emberton; Nathan Lawrentschuk; Massimo Lazzeri; Rodolfo Montironi; Paul L Nguyen; John Trachtenberg; Thomas J Polascik
Journal:  Eur Urol       Date:  2013-06-06       Impact factor: 20.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.